CY1114956T1 - NEW COMPOSITIONS 1- [2- (2,4-Dimethyl-phenylsulfanyl) -phenyl] piperazine - Google Patents

NEW COMPOSITIONS 1- [2- (2,4-Dimethyl-phenylsulfanyl) -phenyl] piperazine

Info

Publication number
CY1114956T1
CY1114956T1 CY20131100823T CY131100823T CY1114956T1 CY 1114956 T1 CY1114956 T1 CY 1114956T1 CY 20131100823 T CY20131100823 T CY 20131100823T CY 131100823 T CY131100823 T CY 131100823T CY 1114956 T1 CY1114956 T1 CY 1114956T1
Authority
CY
Cyprus
Prior art keywords
piperazine
phenyl
phenylsulfanyl
dimethyl
new compositions
Prior art date
Application number
CY20131100823T
Other languages
Greek (el)
Inventor
Astrid-Maria Højer
Pernille Gundorf Drewes
Jens Kateb
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10805414.9A external-priority patent/EP2470166B1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of CY1114956T1 publication Critical patent/CY1114956T1/en

Links

Abstract

Παρέχονται φαρμακευτικές συνθέσεις 1-[2-(2,4-διμεθυλοφαινυλοσουλφανυλο)-φαινυλο] πιπεραζίνης και φαρμακευτικά αποδεκτά άλατα μετά από προσθήκη οξέος σε αυτή που προσαρμόζονται έτσι ώστε να μη λαμβάνει χώρα αποδέσμευση στο στομάχι.Pharmaceutical compositions of 1- [2- (2,4-dimethylphenylsulfanyl) -phenyl] piperazine and pharmaceutically acceptable salts are provided after addition of acid thereto which are adapted to prevent stomach release.

CY20131100823T 2009-08-24 2013-09-20 NEW COMPOSITIONS 1- [2- (2,4-Dimethyl-phenylsulfanyl) -phenyl] piperazine CY1114956T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23622309A 2009-08-24 2009-08-24
DKPA200900950 2009-08-24
EP10805414.9A EP2470166B1 (en) 2009-08-24 2010-08-23 New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine

Publications (1)

Publication Number Publication Date
CY1114956T1 true CY1114956T1 (en) 2016-12-14

Family

ID=58464031

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100823T CY1114956T1 (en) 2009-08-24 2013-09-20 NEW COMPOSITIONS 1- [2- (2,4-Dimethyl-phenylsulfanyl) -phenyl] piperazine

Country Status (1)

Country Link
CY (1) CY1114956T1 (en)

Similar Documents

Publication Publication Date Title
CY1117424T1 (en) BROMODOMAIN BENZODIAZEPINIC SUSPENSION
CR20120058A (en) NEW COMPOSITIONS OF 1 - [2 - (2,4-DIMETIL-PHENYL SULFANIL) -PENYL] PIPERAZINA
CR20110370A (en) SULFONAMIDE DERIVATIVES
NL300998I2 (en) Lusutrombopag or pharmaceutically acceptable salts or solvates thereof
CY1117978T1 (en) THERAPEUTIC USES OF COMPOUNDS WHICH HAVE COMBINED ACTIVITY SERT, 5-HT3 AND 5-HT1A
DK3150198T3 (en) PHARMACEUTICAL COMPOSITIONS OF 3- (6- (1- (2,2-DIFLUOROBENZO [D] [1,3] DIOXOL-5-YL) -CYCLOPROPANCARBOXAMIDO) -3-METHYLPYRIODIN-2-YL) BENZOIC ACID AND ADMINISTRATION
EA201100358A1 (en) DABIGATRAN FOR INTERTEGUAL SURGICAL CATHETERIZATION OF THE HEART
UY32487A (en) PHARMACEUTICAL COMPOSITIONS OF IMMEDIATE RELEASE UNDERSTANDING OXYCODONE AND NALOXONE
MY155288A (en) Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine
MX2010008583A (en) Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid.
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
CU20110113A7 (en) WE REACT AS BETA SECRETASA INHIBITORS
CU20110233A7 (en) HETEROCYCLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
CO6741154A2 (en) Triazolopyridine Compounds
UY31876A (en) PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONA DERIVATIVE
CY1111914T1 (en) METHOD OF COMPOSITION OF IVABRADIN AND THE SALTS ADDED WITH A PHARMACEUTALLY ACCEPTABLE ACID
CY1118886T1 (en) Therapeutic Uses of 1- [2- (2,4-Dimethyl-phenylsulfanyl) phenyl] piperazine
ECSP10010597A (en) NEW CLASS OF PIPERIDINES ESPIRO FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
MX367327B (en) Formulations, salts and polymorphs of transnorsertraline and uses thereof.
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
UY33305A (en) Heterocyclic compounds inhibiting DGAT1
ME00987B (en) New process for synthesiis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EA201000611A1 (en) 4,4-DESIGNED PIPERIDINES
CY1114956T1 (en) NEW COMPOSITIONS 1- [2- (2,4-Dimethyl-phenylsulfanyl) -phenyl] piperazine
WO2011081445A3 (en) Treatment use of ethylamino benzoic acid derivatives